Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search
Fullscreen

For citations:


Kolbin A.S., Gomon Yu.M., Proskurin M.A., Balykina Yu.E. Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(3):412-421. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.210

Views PDF (Rus): 218


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)